James N. Fullerton

3.0k total citations · 2 hit papers
22 papers, 2.2k citations indexed

About

James N. Fullerton is a scholar working on Immunology, Epidemiology and Surgery. According to data from OpenAlex, James N. Fullerton has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 6 papers in Epidemiology and 4 papers in Surgery. Recurrent topics in James N. Fullerton's work include Immune Response and Inflammation (8 papers), Sepsis Diagnosis and Treatment (4 papers) and Immune cells in cancer (4 papers). James N. Fullerton is often cited by papers focused on Immune Response and Inflammation (8 papers), Sepsis Diagnosis and Treatment (4 papers) and Immune cells in cancer (4 papers). James N. Fullerton collaborates with scholars based in United Kingdom, United States and Norway. James N. Fullerton's co-authors include Derek W. Gilroy, Alexander A. Maini, Alastair O’Brien, Derek C. Macallan, Venetia Bigley, Becca Asquith, Amit A. Patel, Lies Boelen, Anthony Rongvaux and Richard A. Flavell and has published in prestigious journals such as Nature Medicine, The Journal of Experimental Medicine and Nature Reviews Drug Discovery.

In The Last Decade

James N. Fullerton

21 papers receiving 2.1k citations

Hit Papers

Resolution of inflammatio... 2016 2026 2019 2022 2016 2017 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
James N. Fullerton 849 461 461 226 190 22 2.2k
William J. Hubbard 826 1.0× 654 1.4× 609 1.3× 320 1.4× 64 0.3× 59 2.6k
George M. Matuschak 871 1.0× 1.0k 2.2× 773 1.7× 631 2.8× 222 1.2× 84 3.5k
Jinbao Li 938 1.1× 872 1.9× 810 1.8× 367 1.6× 53 0.3× 100 2.9k
Rodrig Marculescu 489 0.6× 537 1.2× 1.0k 2.2× 328 1.5× 180 0.9× 157 3.2k
Alexandre Mignon 567 0.7× 713 1.5× 916 2.0× 727 3.2× 283 1.5× 80 3.3k
Barry B. Rubin 522 0.6× 308 0.7× 516 1.1× 392 1.7× 50 0.3× 66 2.3k
Sebastian Weis 491 0.6× 563 1.2× 899 2.0× 165 0.7× 117 0.6× 87 2.2k
Kevin P. Mollen 896 1.1× 626 1.4× 742 1.6× 664 2.9× 46 0.2× 62 3.0k
Thomas A. Neff 1.8k 2.2× 833 1.8× 676 1.5× 672 3.0× 73 0.4× 75 4.6k
Gediminas Cepinskas 675 0.8× 514 1.1× 1.2k 2.6× 591 2.6× 48 0.3× 113 3.5k

Countries citing papers authored by James N. Fullerton

Since Specialization
Citations

This map shows the geographic impact of James N. Fullerton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James N. Fullerton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James N. Fullerton more than expected).

Fields of papers citing papers by James N. Fullerton

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James N. Fullerton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James N. Fullerton. The network helps show where James N. Fullerton may publish in the future.

Co-authorship network of co-authors of James N. Fullerton

This figure shows the co-authorship network connecting the top 25 collaborators of James N. Fullerton. A scholar is included among the top collaborators of James N. Fullerton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James N. Fullerton. James N. Fullerton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Higham, Helen, Lauren Morgan, Cushla Cooper, et al.. (2023). Adopting human factors in early phase and experimental medicine research: A nested pilot study observing controlled human infection with SARS‐CoV‐2. British Journal of Clinical Pharmacology. 90(7). 1586–1599. 2 indexed citations
2.
Drennan, Philip G., et al.. (2022). In vivo human keyhole limpet hemocyanin challenge in early phase drug development: A systematic review. Clinical and Translational Science. 16(3). 357–382. 5 indexed citations
3.
Pritchard, Robyn H., A. A. Zhukov, James N. Fullerton, et al.. (2019). Cell sorting actuated by a microfluidic inertial vortex. Lab on a Chip. 19(14). 2456–2465. 31 indexed citations
4.
Fullerton, James N., Kelly Thompson, Amith Shetty, et al.. (2017). New sepsis definition changes incidence of sepsis in the intensive care unit. Critical Care and Resuscitation. 19(1). 9–13.e21. 7 indexed citations
5.
Fullerton, James N., et al.. (2016). Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation. Journal of Visualized Experiments. 6 indexed citations
6.
Fullerton, James N., et al.. (2016). Intravenous Endotoxin Challenge in Healthy Humans: An Experimental Platform to Investigate and Modulate Systemic Inflammation. Journal of Visualized Experiments. 36 indexed citations
7.
Fullerton, James N. & Derek W. Gilroy. (2016). Resolution of inflammation: a new therapeutic frontier. Nature Reviews Drug Discovery. 15(8). 551–567. 688 indexed citations breakdown →
8.
Motwani, Madhur P., Julia Flint, Roel P. H. De Maeyer, et al.. (2016). Novel translational model of resolving inflammation triggered by UV‐killed E. coli. The Journal of Pathology Clinical Research. 2(3). 154–165. 24 indexed citations
9.
Fullerton, James N., et al.. (2015). Stimulated Whole Blood Cytokine Release as a Biomarker of Immunosuppression in the Critically Ill. Shock. 45(5). 490–494. 41 indexed citations
10.
O’Brien, Alastair, James N. Fullerton, Karen A. Massey, et al.. (2014). Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2. Nature Medicine. 20(5). 518–523. 210 indexed citations
11.
Kreisel, Daniel, et al.. (2014). Inflammatory triggers of acute rejection of organ allografts. Immunological Reviews. 258(1). 132–144. 104 indexed citations
12.
Fullerton, James N., Alastair O’Brien, & Derek W. Gilroy. (2013). Lipid mediators in immune dysfunction after severe inflammation. Trends in Immunology. 35(1). 12–21. 74 indexed citations
13.
Fullerton, James N., et al.. (2012). Is the Modified Early Warning Score (MEWS) superior to clinician judgement in detecting critical illness in the pre-hospital environment?. Resuscitation. 83(5). 557–562. 103 indexed citations
14.
Perkins, Gavin D. & James N. Fullerton. (2011). Who to admit to intensive care?. Clinical Medicine. 11(6). 601–604. 10 indexed citations
15.
Fullerton, James N. & Mervyn Singer. (2011). Organ Failure in the ICU: Cellular Alterations. Seminars in Respiratory and Critical Care Medicine. 32(5). 581–586. 14 indexed citations
16.
Perkins, Gavin D., et al.. (2010). Novel smart backboard improves CPR performance. Resuscitation. 81(2). S11–S11. 5 indexed citations
17.
Perkins, Gavin D., et al.. (2010). The effect of pre-course e-learning prior to advanced life support training: A randomised controlled trial. Resuscitation. 81(7). 877–881. 75 indexed citations
18.
Fullerton, James N., et al.. (2010). Should non-anaesthetists perform pre-hospital rapid sequence induction? an observational study. Emergency Medicine Journal. 28(5). 428–431. 27 indexed citations
19.
Fullerton, James N., et al.. (2010). Critical care outreach. BMJ. c900–c900.
20.
Fullerton, James N., et al.. (2009). Can experienced paramedics perform tracheal intubation at cardiac arrests? Five years experience of a regional air ambulance service in the UK. Resuscitation. 80(12). 1342–1345. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026